Biomarkers for rheumatoid arthritis and usage thereof
US10883146B2 · kind B2 · utility
2Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 2015 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Dec 19, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Biomarkers and methods for predicting risk of a disease in particular RA are provided. Sequences of DNA are obtained. The DNA may be extracted from a sample that is collected from a subject. A relative abundance of a biomarker is then calculated based on the sequences of the DNA. The biomarker comprises a DNA sequence in a genome of Lactobacillus salivarius. A probability of the subject having the disease is obtained based on the relative abundance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.